Shares of Intuitive Surgical (ISRG) have risen 14.2% in the past three months, outperforming the Zacks Medical - Instruments industry’s growth of 3.8% and the broader Zacks Medical sector’s return of 5.4%. ISRG stock has risen 45.7% year to date, primarily due to strong demand for its robotic surgery procedures.The uptrend is likely to continue for the rest of 2024 as improving da Vinci procedures should continue to attract investors going forward. The company’s newly launched da Vinci 5 is also showing str ...